Blog

We have added a new clinical trial and a dose expansion cohort to our roster of brain tumor clinical trials at the Pacific Neuroscience Research Center at Pacific Neuroscience Institute. TRIALS OPEN FOR ENROLLMENT: New Trial Triphase MRZ-112 (NCT02903069): Study of Marizomib With Temozolomide and Radiotherapy in Patients...

We have added a new clinical trial to our roster of brain tumor trials at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Orbus Therapeutics (NCT02796261): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine...

We have recently added a new clinical trial protocol at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Boehringer Ingelheim (NCT 02423525): A Phase I Dose Escalation and CNS Pharmacokinetic Study of the ErbB Family Inhibitor Afatinib in Patients with Recurrent or Progressive Brain...

We are pleased to announce a new clinical trial protocol that is now available at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Inspyr Therapeutics (NCT 02876003):Efficacy, Safety and CNS Exposure of G-202 in Patients with PSMA-Positive Recurrent or Progressive Glioblastoma. Glioblastoma (GBM)...

We have added two new clinical trials to our roster. NEW CLINICAL TRIALS AbbVie / RTOG (NCT 02573324): A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification. This study seeks to determine whether the addition of...

We have a number of ongoing and new clinical trials at the Pacific Brain Tumor Center for patients who may benefit from newer brain tumor treatment options. In our Clinical Trials Round-Up blog series, we will periodically provide an update on the latest clinical trials and studies at our center....